Pharmaceutical Executive September 11, 2024
Michael Wong

A Harvard Business School Healthcare Alumni Association Q&A with Jeremy Goldberg of Arsenal Capital Partners.

Jeremy Goldberg is an Operating Partner of Arsenal Capital Partners (which has greater than $10 billion AUM), a private equity fund where he focuses on networking and sourcing transactions for the healthcare team. He also serves as a Senior Advisor to $75 billion AUM (TPG) Sixth Street Partners and on several private company board of directors

Goldberg has over 25 years of experience, mainly focused on investing and business development in the pharmaceutical and healthcare industries. Goldberg served as Managing Director, Corporate Development for Endo Pharmaceuticals (Nasdaq: ENDP), a leading pain therapeutics company.

Goldberg has served on the Visiting Committees at Dana Farber Cancer Institute...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Trends
Smart rooms are not common, but their benefits could soon make them so
Q&A: CybersolutionsMD CEO on preventing cyberattacks
Q&A: Continuous health monitoring with wearables
Three for 2025: What you need to know about agentic AI, cancer informatics and data security imperatives
From family doc to AI overseer

Share This Article